Process for the preparation of N-aryl-N-hydroxamides
    1.
    发明授权
    Process for the preparation of N-aryl-N-hydroxamides 失效
    制备N-芳基-N-羟基酰胺的方法

    公开(公告)号:US06232492B1

    公开(公告)日:2001-05-15

    申请号:US09380170

    申请日:1999-08-25

    申请人: Juergen Stohrer

    发明人: Juergen Stohrer

    IPC分类号: C07C25906

    CPC分类号: C07C259/06

    摘要: The invention relates to a method for preparing n-aryl-n-hydroxamides, whereby arylhydroxamines are reacted with ketones to n-aryl-n-hydroxamides, without using acyloxindoles-generating solvents.

    摘要翻译: 本发明涉及一种制备正芳基 - 正羟基酰胺的方法,其中芳基羟胺与酮与N-芳基 - 正 - 羟基酰胺反应而不使用产生酰氧吲哚的溶剂。

    Hydroxamic acid derivatives and medicinal utilization thereof
    4.
    发明授权
    Hydroxamic acid derivatives and medicinal utilization thereof 失效
    羟肟酸衍生物及其药用

    公开(公告)号:US06610729B1

    公开(公告)日:2003-08-26

    申请号:US09701043

    申请日:2000-11-22

    IPC分类号: C07C25906

    摘要: The present invention relates to a hydroxamic acid derivative of the formula (I) wherein each symbol is as defined in the specification, a pharmacologically acceptable salt thereof, a pharmaceutical composition containing the derivative or a salt thereof, and to pharmaceutical use thereof. The hydroxamic acid derivative and a pharmacologically acceptable salt thereof of the present invention have an inhibitory activity of TNF &agr; production, and are useful for, for example, the prophylaxis and treatment of the diseases such as autoimmune diseases and inflammatory diseases (e.g., sepsis, MOF, rheumatoid arthritis, Crohn's disease, cachexia, myasthenia gravis, systemic lupus erythematosus, asthma, I type diabetes, psoriasis and the like), and the like.

    摘要翻译: 本发明涉及式(I)的异羟肟酸衍生物,其中各符号如说明书中所定义,其药理学上可接受的盐,含有其衍生物或其盐的药物组合物及其药学用途。 本发明的异羟肟酸衍生物及其药理学上可接受的盐具有TNFα产生的抑制活性,可用于例如自身免疫性疾病和炎症性疾病(例如败血症, MOF,类风湿关节炎,克罗恩病,恶病质,重症肌无力,系统性红斑狼疮,哮喘,I型糖尿病,牛皮癣等)等。